Diabetes https://www.bioworld.com/rss en-us US FDA pondering next steps for CNPV http://www.bioworld.com/articles/729950 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729950-us-fda-pondering-next-steps-for-cnpv Paper airplanes with red leading Medtronic cuts earnings guidance on Minimed factors http://www.bioworld.com/articles/729905 Thu, 26 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729905-medtronic-cuts-earnings-guidance-on-minimed-factors Scissors cutting stack of $100 bills Minimed secures FDA nod for next-gen insulin pump http://www.bioworld.com/articles/729746 Thu, 19 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729746-minimed-secures-fda-nod-for-next-gen-insulin-pump Minimed Flex system Minimed Flex system. Credit: Minimed Group Inc. Study: GLP-1RAs associated with less risk of mental illness getting worse http://www.bioworld.com/articles/729743 Thu, 19 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729743-study-glp-1ras-associated-with-less-risk-of-mental-illness-getting-worse Mental illness art concept Triple crown: T2D purse for Lilly’s phase III retatrutide? http://www.bioworld.com/articles/729742 Thu, 19 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729742-triple-crown-t2d-purse-for-lillys-phase-iii-retatrutide Hand weight, sneakers, scale, measuring tape, apple, injector and glucose monitor Minimed IPO raises $560M as it splits from Medtronic http://www.bioworld.com/articles/729356 Fri, 06 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729356-minimed-ipo-raises-560m-as-it-splits-from-medtronic Businessman and IPO virtual screen Ninth Circuit agrees with Lilly in royalty dispute http://www.bioworld.com/articles/729246 Thu, 26 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729246-ninth-circuit-agrees-with-lilly-in-royalty-dispute Vivtex’s oral drug delivery approach draws Novo in $2.1B deal http://www.bioworld.com/articles/729200 Wed, 25 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729200-vivtexs-oral-drug-delivery-approach-draws-novo-in-21b-deal GI-ORIS-pic-Vivtex-2-25.jpg GI-ORIS, or “GI tract on a chip” screening system. Credit: Vivtex Corp. Medtronic’s diabetes unit Minimed seeks $784M in IPO http://www.bioworld.com/articles/729196 Tue, 24 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729196-medtronics-diabetes-unit-minimed-seeks-784m-in-ipo IPO, coins, financial chart Viking to push oral GLP-1/GIP drug into phase III obesity trial http://www.bioworld.com/articles/728847 Thu, 12 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728847-viking-to-push-oral-glp-1-gip-drug-into-phase-iii-obesity-trial Pills and bottle Sava sees positive data on microsensing tech http://www.bioworld.com/articles/728718 Tue, 10 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728718-sava-sees-positive-data-on-microsensing-tech Sava Technologies' multi-molecule biosensor technology Sava's multi-molecule biosensor technology. Credit: Sava Technologies Ltd. China NMPA approves Sciwind’s GLP-1 injection for diabetes http://www.bioworld.com/articles/728623 Tue, 03 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728623-china-nmpa-approves-sciwinds-glp-1-injection-for-diabetes Medtronic to acquire Cathworks for $585M http://www.bioworld.com/articles/728546 Tue, 03 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728546-medtronic-to-acquire-cathworks-for-585m Cathworks Ffrangio system Cathworks' Ffrangio system is an AI guidance system for coronary artery disease management. Credit: Cathworks Ltd. China NMPA approves Sciwind’s GLP-1 injection for diabetes http://www.bioworld.com/articles/728531 Mon, 02 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728531-china-nmpa-approves-sciwinds-glp-1-injection-for-diabetes Fractyl’s Revita reduces post-GLP-1 weight regain 70% http://www.bioworld.com/articles/728273 Thu, 29 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/728273-fractyls-revita-reduces-post-glp-1-weight-regain-70 Illustration of Revita DMR in intestine Revita duodenal mucosal resurfacing system. Credit: Fractyl Laboratories Inc. Beta Bionics posts strong results in inaugural public company year http://www.bioworld.com/articles/728253 Tue, 27 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/728253-beta-bionics-posts-strong-results-in-inaugural-public-company-year Ilet2.jpg Beta Bionics Inc.’s Ilet automatic insulin delivery system Abbott misses Q4 expectations http://www.bioworld.com/articles/728077 Thu, 22 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/728077-abbott-misses-q4-expectations Abbott sign Credit: Abbott Laboratories Vicentra secures additional $13M for Kaleido insulin patch pump http://www.bioworld.com/articles/727605 Fri, 09 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/727605-vicentra-secures-additional-13m-for-kaleido-insulin-patch-pump Kaleido user Kaleido insulin patch pump system. Credit: Vincentra ​Positive changes ahead for diabetes in 2026 http://www.bioworld.com/articles/727565 Mon, 05 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/727565-positive-changes-ahead-for-diabetes-in-2026 Art concept for metabolism International consensus on ketone monitoring emerges http://www.bioworld.com/articles/726752 Thu, 11 Dec 2025 11:00:00 -0500 https://www.bioworld.com/articles/726752-international-consensus-on-ketone-monitoring-emerges Scientists shaking hands in the lab Fractyl procedure sustains weight loss after GLP-1s http://www.bioworld.com/articles/726447 Tue, 02 Dec 2025 11:00:00 -0500 https://www.bioworld.com/articles/726447-fractyl-procedure-sustains-weight-loss-after-glp-1s Illustration of Revita DMR in intestine Revita duodenal mucosal resurfacing system. Credit: Fractyl Laboratories Inc. Medicare’s competitive bidding program draws opposition http://www.bioworld.com/articles/726445 Tue, 02 Dec 2025 11:00:00 -0500 https://www.bioworld.com/articles/726445-medicares-competitive-bidding-program-draws-opposition Medicare puzzle OIG sees potential for savings in Medicare CGM coverage http://www.bioworld.com/articles/726404 Wed, 26 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/726404-oig-sees-potential-for-savings-in-medicare-cgm-coverage Medicare puzzle Cha Group to Acquire Majority Stake in Kakao Healthcare http://www.bioworld.com/articles/726394 Tue, 25 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/726394-cha-group-to-acquire-majority-stake-in-kakao-healthcare South Korean won CMS terminates Treatment Choices model in ESRD final rule http://www.bioworld.com/articles/726393 Tue, 25 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/726393-cms-terminates-treatment-choices-model-in-esrd-final-rule CMS logo and website FDA clears Dexcom Smart Basal for insulin optimization http://www.bioworld.com/articles/726211 Wed, 19 Nov 2025 11:00:00 -0500 https://www.bioworld.com/articles/726211-fda-clears-dexcom-smart-basal-for-insulin-optimization Dexcom G7 CGM Dexcom Inc.’s G7 continuous glucose monitor. Halloween turns scary for Dexcom despite strong Q3 http://www.bioworld.com/articles/725473 Fri, 31 Oct 2025 12:00:00 -0400 https://www.bioworld.com/articles/725473-halloween-turns-scary-for-dexcom-despite-strong-q3 Dexcom G7 CGM Dexcom Inc.’s G7 continuous glucose monitor. Adocia’s Biochaperone Lispro phase III T1D data positive in China BioWorld, the firm having recently gained positive top-line phase III results of Tonghua Dongbao Pharmaceutical Co. Ltd.’s THDB-0206 injection (Biochaperone Lispro) in diabetes patients in China.]]> http://www.bioworld.com/articles/725680 Tue, 28 Oct 2025 11:00:00 -0400 https://www.bioworld.com/articles/725680-adocias-biochaperone-lispro-phase-iii-t1d-data-positive-in-china Insulin pen Adocia’s Biochaperone Lispro phase III T1D data positive in China BioWorld, the firm having recently gained positive top-line phase III results of Tonghua Dongbao Pharmaceutical Co. Ltd.’s THDB-0206 injection (Biochaperone Lispro) in diabetes patients in China.]]> http://www.bioworld.com/articles/725403 Fri, 24 Oct 2025 11:00:00 -0400 https://www.bioworld.com/articles/725403-adocias-biochaperone-lispro-phase-iii-t1d-data-positive-in-china Insulin pen Dexcom faces class action lawsuit following FDA warning http://www.bioworld.com/articles/725144 Tue, 21 Oct 2025 12:00:00 -0400 https://www.bioworld.com/articles/725144-dexcom-faces-class-action-lawsuit-following-fda-warning US flag, gavel, book